MPIP: Melanoma Patients Information Page

The MPIP is the oldest and largest community of people affected by melanoma hosted through the Melanoma Research Foundation. It is designed to provide support and information to caregivers, patients, family and friends. Once you have been touched by melanoma—either as a patient or as a family member or friend of a patient—you become part of a community. It is not a community anyone joins willingly. But if you must be part of this group, you will find no better place to find the tools you need in your journey with this cancer, and the friends who can make that journey more bearable.

The information on the bulletin board is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

Expand/ Collapse Topic
Replies By
View Topic
Anonymous's picture
Replies 5
Last reply 6/1/2013 - 8:07pm
Replies by: Anonymous, Lori C, Bubbles, Janner
Research May 28, 2013

Four-year Overall Survival Rates 38-50% Using Ipilimumab


Ann. Oncol. 2013 May 10;[EPub Ahead of Print], JD Wolchok, JS Weber, M Maio, B Neyns, K Harmankaya, K Chin, L Cykowski, V de Pril, R Humphrey, C Lebbé


Almost 500 patients treated with ipilimumab with a minimum of 4 years follow-up were analyzed in this study. Four-year overall survival rates were 38-50% using ipilimumab 10mg/kg in the first line setting and 20-28% in the second line setting.


Background: This analysis was carried out to evaluate the long-term survival of patients with metastatic melanoma who received ipilimumab, a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte antigen-4, in clinical trials.


Patients and Methods: Patients received ipilimumab in one of three completed phase II clinical trials (CA184-008, CA184-022, and CA184-007). Previously treated patients were enrolled in all studies, and treatment-naïve patients were also included in study CA184-007. Patients received ipilimumab at a dose of 10 mg/kg in studies CA184-008 and CA184-007, and at doses of 0.3, 3, or 10 mg/kg in study CA184-022. Ipilimumab was given every 3 weeks for four doses, and eligible patients could receive ipilimumab maintenance therapy every 12 weeks. In study CA184-022, patients could cross over to be retreated with ipilimumab at 10 mg/kg upon disease progression. Ongoing survival follow-up is conducted in a companion study, CA184-025.


Results: Four-year survival rates [95% confidence interval (95% CI)] for previously treated patients who received ipilimumab at 0.3, 3, or 10 mg/kg were 13.8% [6.1-22.5], 18.2% [9.5-27.6], and 19.7% [13.4-26.5] to 28.4% [13.9-44.2], respectively. In treatment-naïve patients who received ipilimumab at 10 mg/kg, 4-year survival rates were 37.7% [18.6-57.4] to 49.5% [23.8-75.4].


Conclusions: These results demonstrate durable survival in a significant proportion of patients with metastatic melanoma who received ipilimumab therapy.

Annals of Oncology
Four-Year Survival Rates for Patients With Metastatic Melanoma Who Received Ipilimumab in Phase II Clinical Trials
Ann. Oncol. 2013 May 10;[EPub Ahead of Print], JD Wolchok, JS Weber, M Maio, B Neyns, K Harmankaya, K Chin, L Cykowski, V de Pril, R Humphrey, C Lebbé

Login or register to post replies.

Becky's picture
Replies 2
Last reply 5/30/2013 - 8:46am
Replies by: Brendan, Phil S

But who  is counting ( I am!)

My son was diagnosed in July 09 just beofre his 21st birthday, oral melanoma (toungue) one postive node, year of interferon, a few scares a long the way.

Pet scan yesterday, NED! I have been extra nervous becuase his oncologist decided scans once a year were fine ( he is not a melanoma specialist) so it has been a year since his last one. Plus, next week he is moving to NYC because he got accepted to a fellowship that will keep him there (teaching math) for 5 years..sad he will be 3000 miles away but excited for him.

I really want to thank all of you who gave me support directly or indirectly..I dont post often but I read daily

Keep fighting


Login or register to post replies.

In the United States, the wholesale acquisition cost of Tafinlar is $7,600 for a 30-day supply and Mekinist will be $8,700 for a 30-day supply, according to a spokesperson for GlaxoSmithKline. 

Read more: UPDATED: GlaxoSmithKline gains FDA OK on two genetically targeted melanoma drugs - FierceBiotech

Advocate for your own treatment.. Stage 4 Melanoma NED Surgery,Radiation, Temodar 300Mg July 2009-March 2010, then "Phase I Study of Anti-PD-1 Human Monoclonal Antibody MDX-1106 and Vaccine Therapy"

Login or register to post replies.

NYKaren's picture
Replies 3
Last reply 5/29/2013 - 9:05pm

Hi everyone,

As many already know, I have been on Zelboraf, intermittent dosing, since the beginning of the year. Three weeks on, two weeks off.
During the last off period, previously-flattened (meaning disease-free) mets on scalp/ear began growing again.

As some also know, I've been trying to get into an anti PD1 trial for close to 2 years now. The restrictions have always stopped me, or when a new trial opened, I didn't have the measurable disease required, having been a partial responder to several therapies. So when I had this "progression", which halted upon resuming Zel, I photographed it & sent to onc. We decided together that since this will LIKELY turn into measurable disease, to stop Zel yesterday. MRI of brain & CT of chest & abdomen scheduled for 2 weeks from today. he said MRI should pick up measurable disease. I just feel that now is the time, because if PD1 fails me, I still have working Zel in my back pocket. Of course I'm second-guessing myself that I should have started last week, etc. etc. I guess that if after 2weeks they're growing but not to 1cm required, I can postpone a week. But as our beloved Boots used to say: Don't Look Back; Don't Back Down.

That's my story and I'm sticking to it, albeit nervously.

Don't Stop Believing

Login or register to post replies.

becky62's picture
Replies 3
Last reply 5/29/2013 - 9:58pm

I've had two in fusions of Yervoy and I have received the first claim submitted to my insurance company.  My provider charged my insurance company over $205,000 for one infusion.  My insurance company has a contract with the provider for $102,000 for one infusion.  My dosage was 336 mg.  I thought this drug was about $30,000 for 200mg.  Is this normal for providers to charge this kind of money for drugs?  I am shocked.  My insurance has a yearly cap of $250,000.  I'll run out of coverage with my 3rd infusion.  Any advice or help with this kind of situation would be greatly appreciated.

Login or register to post replies.

Tim--MRF's picture
Replies 12
Last reply 6/2/2013 - 7:48am

The FDA just approved two new drugs for treating metastatic melanoma.  One is a BRAF inhibitor, similar to Zelboraf (vemurafenib).  The other is a MEK inhibitor.

The MEK inhibitor can be used in patients whose tumors do not have the BRAF mutation, and also is being tested in uveal melanoma.

The biggest use, though will likely be in combining the BRAF and MEK inhibitors.  Studies have shown that patients with the BRAF mutation who were treated with the combination had better response, longer response, and fewer side effects. 

Here is the press release:

This is big news for the melanoma community, and a great step forward!  We still have a long way to go, but two new drugs is a good thing.


Login or register to post replies.

flvermonter's picture
Replies 5
Last reply 5/30/2013 - 7:52am

Where would I go to look at help for llung cancer?  My husband has stage iiic melanoma and stage 1 lung cancer.  They have only the clinical stage for the lung cancer until they remove the cancer, and surrounding lymph nodes.  You have all been so helpful to me in regard to his melanoma, but not sure where to go for the lung cancer experience and help. 


His lung cancer clinical diagnosis is that one was a 1.1cm, that is now 1.5cm and a 1.9cm that is now a 2.1cm. 

Thanks, Mary

Hugs to all, patients and care givers.

Login or register to post replies.

Who_am_i's picture
Replies 3
Last reply 5/30/2013 - 5:17pm
Replies by: ecc26, NYKaren, POW

I had my biopsy results 5/22. My first oncologist/ surgeon team meeting is not until 6/5. My derm told me I would be fast tracked for SNB and excision. Now that is not happening till who knows when. I know I'm supposed to be patient but must admit it is starting to get harder.


Login or register to post replies.

Anonymous's picture
Replies 2
Last reply 5/29/2013 - 10:42am
Replies by: Linny, Janner

I am really scared. Until today, melanoma was hardly on my radar. But the other day, a colleague came up to me after a meeting and suggested I get the mole on my arm checked out. I took her seriously because I have been wondering if it has been changing over last few months myself, but clearly haven't been paying enough attention, or I would have been to the doctor already.  I went today and the doctor took it really seriously, I was shocked. He asked me all sorts of things including family history of melanoma.  I am travelling at the moment, have an appointment with a specialist next week to have it excised and checked. The doctor I saw today made me promise to get it out as soon as I was home and definitely in no more than a week or so. Of course have been looking on internet today and reading, and my instinct says that this is a melanoma. It fits almost of those abcde or whatever things (except family history). Have been hoping to find some reassuring statistics saying that only a small proportion of spots sent off for testing are melanomas but can't find anything of the sort, which is making me worried. I can't stop crying, I am really nervous. Am I realistic to be worried?  Are there any reassuring statistics out there? I really appreciate your taking the time to read this and any advice you might be able to provide. 

Login or register to post replies.

Anonymous's picture
Replies 3
Last reply 5/29/2013 - 9:45am
Replies by: Janner, Anonymous

My husband got diagnosed as lentigo maligna of the left ear auricle from a punch biopsy. (Mar, 2013)

He had a wide excision surgery at another hospital (Apr, 2013) and here is the exact copy of the post-surgery pathology report.


Name of the specimen:  Skin

Test items:  Gross Photo (2ea)


                     Immun[Melanoma Ag(HMB45)]



                    [Resected Specimen]no more than 6  Histopath Exam



The specimen labeled as  “left ear choncha area” consists of a portion of choncha, measuring 3.0X2.8X1.0cm. The skin shows a dark brownish pigmented lesion, measuring 0.7X0.4cm. It is 1.0cm, 1.0cm, 1.3cm, and 1.1cm apart  from the superior,  inferior, anterior and posterior resection margins. Multisected and representative sections are embedded in block A1 to A8.

Color key:   yellow: anterior,  red: superior,  blue:inferior,  green: posterior,  black: deep



Skin, ear, choncha, left, wide excision:

  1. Primary  tumor diagnosis:  Lentigo malignant melanoma
  2. Level of invasion(Clark level):
    1. Confined to the epidermis,

With all tumor cells above the basement membrane

      Note) Use only with thickness 1.0mm or less than 1.0mm(otherwise omit)

      3. Epidermal  ulceration:  Absent

      Note) Difined as the absence of an intact epidermis overlying a major portion of the primary melanoma


      4. Mitotic rate: 0/mm2

      5. Resection margin:  Margins  are free of tumor (superior: 1.0cm, inferior:  1.0cm, anterior: 1.3cm, posterior: 1.1cm, deep: 0.4cm)

      6. Additional features:

Lymphovascular invasion:  Absent

Neurotropism: Absent

Intraepidermal pattern(lentiginous)

Cell type(epithelioid)

Associate nevus(not  identified)

Lymphocytic infiltrate(non-brisk)

Desmoplasia: Absent

Tumor regression: Absent

      Note)  1. The result of immunohistochemistry;

HMB45: Positive

Melan-A: Positive

 S-100: Positive

 Ki-67 labelling index:  <5%   

                2.  Mapping is done.

                3. Intradepartment consultation is done.



I left what looks like spelling errors to me like “choncha” and “difined” the way they are, as I am not exactly an expert on these things.


My questions are:

  1. What is “lentigo malignant melanoma”? I have seen information about “lentigo maligna” and” lentigo maligna melanoma” but I have never heard of “lentigo malignant melanoma”.  Is it a spelling mistake? Or is it something else?
  2. Our dermatologist had said “lentigo maligna” is different from “lentigo maligna melanoma”, in that the former is a precursor to cancer, for which wide excision is required to prevent it from becoming a cancer. He said that unlike the latter, PET scan is not necessary for “lentigo maligna”.

But the surgeon he referred us to said “lentigo maligna” is one of the four major types of melanoma and prescribed PET-CT and CT scan, saying the parotid gland possibly has to be removed. This confusion and the conflicting information was the major reason why we changed hospitals.

Anyway, our new surgeon(a very specialized ear-reconstruction surgeon) said, after the surgery was done and the final pathology report was written, that my husband’s final diagnosis “lentigo malignant melanoma” is correct, but it is still the same diagnosis as the initial biopsy result. This doesn’t make any sense to us. Who/what should we trust and what should we do?

      3. What do the items in the parenthesis mean? And the result of the immunohistochemistry?

Intraepidermal pattern(lentiginous)

Cell type(epithelioid)

Associate nevus(not  identified)

Lymphocytic infiltrate(non-brisk)

       4. Is there a chance that the bad cells have spread to other parts of the body, because the initial punch biopsy cut into the tumor? One of the surgeons who did the surgery(a resident) mentioned it. This makes me really scared.


The whole medical process seems to be very disorganised and it is very confusing and disappointing.  I live in an Asian country where skin tumors are very rare and my husband is a Caucasian.  I couldn’t find any information on these anywhere in my native language. I will really appreciate your help. Thank you very much for reading this long post.


Login or register to post replies.

Anonymous's picture
Replies 9
Last reply 5/30/2013 - 12:12pm
Replies by: Anonymous, michelleg, BrianP, JGreen, kpcollins31, hbecker, Janner

Just found out a family member has stage iv melanoma - mets in lungs, liver, and lymph. We all live in North Carolina and had an initial visit at duke (not very impressed with staff there so far - does anyone have experience? I cant get over how long it takes to schedule anything). They recommend il-2 as first line treatment followed by ippi (or something like that) if il-2 doesn't work.

Here's my question: is that standard treatment? Is it worth getting a second opinion? My understanding is that duke has the best melanoma treatment in nc - wondering if its worth getting an opinion from another oncologist.

Sorry! This is all still new...

Login or register to post replies.

bkinman's picture
Replies 2
Last reply 5/28/2013 - 9:59pm
Replies by: NYKaren, aldakota22

I have been on Z since Feb 2013 with only one "holiday" from the med.  liver met shrank from 4cm to 2.2 from Feb to Apri while on met. Have been having the joint pain associated with Z since the beginning. Yesterday afternoon started having some mild discomfort in my right shoulder blade exascerbated when I take a deep or semi deep breath.  Go worse as the night wore on.  Now sharp pain on deep breath.  Has anyone had the joint pain in your shoulder blade or do you think it could be something else?

I had some small nodules in lungs on scans in Feb and April.  no change in April. Too small to call mass. No PET yet to see if they show up hot. Also, have lytic lesions on spine. One causing fractured verterbrae.  Had radiation on it Sept 2012. Have not had any pain from fracture in couple months.

Do you think this is just from Z or could it be lung mets or bone mets? I figured I would give it a couple days and see if it got better like the joint pain from the Z does; if not, then I go see my Oncologist. Thought I would ask you guys in meantime.


Thanks in advance.

Becky in Alabama

Login or register to post replies.

Replies by: POW

I'm now more nervous than before. I took your advice and I just picked up a copy of my pathology report here is what it says:



Skin, left medial foot (excisional biopsy):
ULCERATED NODULAR AND INFILTRATING MELANOMA (BRESLOW DEPTH >5 MM), EXTENDING TO THE DEEP MARGIN. Immunostains (Melan A, cytokeratin 5/6, cytokeratin 7) are confirmatory. Positive and negative controls stain appropriately. Focal lymphatic invasion is noted. Dr. Sahmel has seen the slide and concurs.
Only a small amount of possible in situ melanoma is seen. While this can be explained by ulceration, clinical correlation is recommended to exclude metastatic melanoma.


Procedure: EXCISION
Specimen Laterality: LEFT
Tumor Size: 1.5 CM IN WIDTH
Macroscopic Satellite Nodule(s): NOT SEEN
Maximum Tumor Thickness: > 5 MM
Clark Level: AT LEAST LEVEL 4
Ulceration: PRESENT
Margins: DEEP MARGIN POSITIVE FOR INFILTRATING MELANOMA. Because of the polypoid nature of the lesion, there is essentially no lateral margin to the specimen that is distinct from the deep margin.
Microsatellitosis: NOT SEEN
Lymphovascular Invasion: PRESENT
Metastases: UNKNOWN
Pathologic Staging (pTNM): T4b NX MX


Gross Description: blah blah blah

This is concerning to me. Can someone give input as to what this means?

Thank you.

Login or register to post replies.

Replies by: POW, Rebecca and Bob


I am stage 4 melanoma survivor who is assessing the risk of pregnancy after cancer.  I have been in remission for 6 years and would love to start creating a family.
I am in the process of researching everything there is to know about pregnancy and melanoma.  I have found many studies about stage 1, 2 and even stage 3, but am yet to find anything on stage 4 survivors.  Is there anyone out there that is a stage 4 survivor that has had a successful pregnancy or know anyone who has?
 Thank you in advance for any help you are able to offer me.

Login or register to post replies.

ecc26's picture
Replies 12
Last reply 5/30/2013 - 4:49pm

Hello everyone,

I'm 31 years old and was first diagnosed with melanoma from a mole on my upper back in Jan 2011. At the time I was a stage 3 with only 1 lymph node testing positive for any melanoma (after complete lymph node resection of the right axillary (armpit) area). I completed a full year of interferon and just prior to the end of that therapy found a mass in the scar tissue from the lymph node surgery. That was removed (along with any other tissue that might have lymph nodes in it that they could find) in July of 2012. The mass was melanoma and they couldn't tell if it had been a lymph node or not by the time they took it out. In November 2012 I found (and biopsied) a very small, irritated mass on my left lower abdome that turned out to be melanoma and that put me into stage 4.

A rush of imaging and other testing got me ready to start IL2 in December 2013, which my team of local oncologists, specialists at Roswell Park in Buffalo, NY and myself decided was the best first option. My scans showed only 3 mets, all subQ, with 2 tiny (questionable) lung mets, but by the time I finished my first week of IL2 I had found at least 4 more subQ's. I had severe side effects from the IL2 and they cancelled the second week, opting instead to rescan in one month to determine if there had been any benefit. After some arguing on my part about the scans (there had been some apparent progresstion since the previous scan, but I had found tumors prior to the start of IL2 that had not been visible on the previous scan so I argued for another try with the IL2) I checked back in for a second round. I tolerated round 2 much better than round 1 and was able to complete both weeks. 8 weeks later (march 2013) the scans showed that with the exception of 2 tumors (both subQ) ALL of my other tumors had either shrunk or dissapeared. My husband and I were thrilled and happy to check in for round 3 thinking that we had gotten this thing under control.

By the end of the second week of round 3 I could feel that the last 2 tumors that hadn't shrunk on the scans were shrinking and I was on coud 9. Less than a week after I got home from the hospital after round 3 though I had a very sore area over my left pectoral muscle that made me worry. 2 days later I had another sore spot on my lower abdomen. I made an appointment and long story short I now have over a dozen new subQ tumors- several of which have appeared with very large bruising. More than half of them are concentrated in my left breast. I have several questions in my search for information:

1) Has anyone else had an apperant good response to IL2 then had a relapse (and if so, does anyone know of anyone that relapsed so fast)?

2) How common is it to have pain/bruising with the appearance of subQ mets? I've had several subQ's before, but never the inflamation/bruising. Does this mean it's worse this time?

3) I've been told that I have to have failed Ipi before I can begin a clinical trial, but I'm really worried that with the speed tumors are popping up I won't survive the 6 months it takes to determine if I've failed- any thoughts from anyone that has tried Ipi?

4) I think it's odd that so many are concentrated in my breast- has anyone else experienced this "clustering" of tumors? Also, of all the tumors, there are only 2 on the right side of my body- all others are on the left- again has anyone else experienced this sort of "one sided disease"? I had also noticed during the IL2 that the tumors on the left side of my body (the subQ's that I could feel) seemed to respond slower/less than those on the right side.


I had a CT late last week and I get the resluts to day- I'm more nervous than I think I've been for any of my appointments ever. 



Thank you all for your replies so far. Many of you expressed a need to be informed and active in the decision making process and I couldn't agree more. It's your body and your future and you need to have a say. Rest asured, I'm no push over when it comes to medical anything and I obtained my veterinary degree (which many people, physicians included, don't realize is nearly idenitcal to a human medical degree and certainly just as expensive) just 6 months before my diagnosis and since then have been reading all the same information as any doctor I've been speaking to. For the most part they enjoy my medical expertise as it allows them to discuss factors and options in greater detail than they often are with other patients, but it's taken some getting used to for them with regards to me insisting on seeing all of my imaging for myself (not just relying on reports, etc and I'm entirely unsatisified with human pathology reports- there's almost no usable information in them in comparison to what we get for veterinary path reports) and there have been times when I've argued with their opinions. I'm a regular reader of the research and am very familiar with how trials work, etc. I'm very comfortable with the science and frankly hadn't posted anywhere before becuase my brain is much better with studies and statistics, but I was running into trouble trying to track down statitics to answer some of my questions about what was happening to me now. 

With regard to the BRAF mutation, at some point late in 2012 (right around the time I started the IL2) I was told that I had been tested for the BRAF and was positive for the mutation (meaning I am eligilble for the BRAF inhibitors), but there seems to be some trouble tracking that result down, making me wonder if I really was tested or if someone mis-spoke when they told me I was positive. I generally insist on getting copies of all my test results (it helps me process to see them for myself and it gives me a nice portfolio to take with me to specialists, etc) but dropped the ball on that one- should have gotten a copy at the time. 

My appointment today was as good as it was likely to get, I suppose. The CT showed that so far the only new tumors are subQ, although I still need to get a brain MRI to rule in/out any cranial mets. I still have the 2 small lung mets that were present since around the time I started IL2 but they haven't grown and the tumor in the body of T10 that was causing me so much trouble in February has shrunk even more than it had in my scan one month ago. In addition, with the exception of 1 tumor (which is now half the size it was) all of the subQ mets from before/during the IL2 are gone. So It appears that the IL2 did do some good, just not enough/not as much as I and my doctors thought it was. Given these results and the realization that the anti-PD1 trial being opened by the specialist I had been seeing was randomized with chemo in addition to requiring trying Ipi first we (myself and my local oncologist) have decided to schedule an appointment at Dana-Farber in Boston, MA to discuss possibly joining one of their trials, etc. I have to wait another 1-2 weeks anyway before starting either a trial or Ipi since I'm so close to my last round of IL2 so it makes sense to maybe take a look at some other area cancer centers and see what's available for me. I'm also curious about the T-cell therapy trials, although I haven't had time to research the trial results, etc much yet.

Thanks again everyone for posting and for the info about your experiences and trials- it's really not that easy to research what trials are available or rather what the mechanism/action of the drug being tested is.No one wants to divulge their reserarch before it's patented, but it can be hard to sift out which are the PD1 and which are other less promising therapies.

Login or register to post replies.